Companies

Cassidy Bio

cassidybio.com

An AI-first biotechnology company building a programmable platform for gene editing design.

Employees11-50
Funding$8M
Healthcare AIFoundation Model ProviderB2B SaaSSeed$1M-$10M

About

Cassidy Bio is an AI-first biotechnology company that builds a programmable platform for gene editing design. Using genomic foundation models, it replaces traditional trial-and-error design with predictive workflows for guides, enzymes, and delivery contexts. The company targets developers of advanced genetic medicines and therapies.

Active Roles

0

No active roles right now.

Get notified when they post

Key Investors

Ahren Innovation Capital, Lool Ventures, 10D VC, AstraZeneca, Merck KGaA